Company Intelligence

20n

20n provides enterprise-grade artificial intelligence solutions, delivering specialized Using AI to predict biochemistry for manufacturing and therapeutics technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
San Francisco, United States
Website
20n.com
Founded
2015
Employees
2
Stage
Early
Status
Inactive
Products
1
Reports
8
Last reviewed
Aug 2026
AI in Healthcare Early Inactive

Overview

What this company is, what it builds, and who it serves.

20n is a Healthcare AI company based in San Francisco, United States, founded in 2015.

20n develops using AI to predict biochemistry for manufacturing and therapeutics.

What it does

Through the deployment of Using AI to predict biochemistry for manufacturing and therapeutics, 20n provides computational automation and data intelligence for organizations operating in Artificial Intelligence.

What it builds

Using AI to predict biochemistry for manufacturing and therapeutics

Why It Matters

20n provides enterprise-grade artificial intelligence solutions, delivering specialized Using AI to predict biochemistry for manufacturing and therapeutics technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

  • 20n Healthcare

    Explore 20n by 20n. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and FAQs.

    View product intelligence

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

20n

Industry

Products

Capabilities

  • Using AI to predict biochemistry for manufacturing and therapeutics

Features

  • Using AI to predict biochemistry for manufacturing and therapeutics

Country

United States

Official Resources

Official and developer links on file for this company.

Frequently Asked Questions

What does 20n do?

20n specializes in artificial intelligence, developing Using AI to predict biochemistry for manufacturing and therapeutics to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is 20n based and when was it founded?

20n is based in United States and was founded in 2015.

What are the main products offered by 20n?

The flagship platform from 20n is Using AI to predict biochemistry for manufacturing and therapeutics, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of 20n?

20n primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.